About Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH
Das Berufsgenossenschaftliche Universitätsklinikum Bergmannsheil gGmbH bildet eine nicht landeseigene Universitätsklinik am Universitätsklinikum der Ruhr-Universität Bochum. Es gehört zur Unternehmensgruppe der BG Kliniken.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Artu Biologicals
3
Medtronic Bakken Research Center
3
Ruhr University of Bochum
3
Boehringer Ingelheim
2
Celgene
2
Edwards Lifesciences
2
Knopp Biosciences
2
Medtronic Cardiac Rhythm and Heart Failure
2
ResMed
2
United Therapeutics
2
Clinical Trials at Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH
During the past decade, Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 16 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
X-Change HF - Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure
2003-10-01
2008-08-01
Terminated
36
SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)
2002-05-01
2011-08-01
Completed
116
CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation
2003-12-01
2007-01-01
Terminated
100
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy
2006-12-01
2008-03-01
Completed
605
Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure
2008-02-01
2015-06-01
Completed
1,325
A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis
2008-12-01
2011-12-01
Unknown status
374
Long-term Efficacy and Safety Study With Oralgen Grass Pollen
2007-08-01
2009-01-01
Completed
356
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Artu Biologicals" with 3 trials
sponsored, "Medtronic Bakken Research Center" with 3 trials sponsored, "Ruhr University of Bochum" with 3 trials sponsored and "Boehringer Ingelheim"
with 3 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH"
#1 collaborator was "Medtronic" with 3 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH
According to Clinical.Site data, the most researched conditions in "Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH" are
"Heart Failure" (4 trials), "Allergic Rhinoconjunctivitis" (3 trials), "Crohn Disease" (3 trials), "Amyotrophic Lateral Sclerosis" (2 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH
Most popular intervention types in "Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH" are "Drug" (19 trials), "Device" (12 trials), "Other" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Etrolizumab" (4 trials), "Oralgen" (3 trials), "Dexpramipexole" (2 trials) and "GED-0301" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH
The vast majority of trials in "Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH" are
36 trials for "All" genders.
Clinical Trials Status at Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH
Currently, there are NaN active trials in "Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil GmbH, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 10 trials that are defined as “Not Applicable".